100 related articles for article (PubMed ID: 1101934)
41. [Comparison of chemotherapy CHOP vs. CHOP/VIA in the treatment of aggressive non-Hodgkin's lymphoma: a randomized multicenter study of 132 patients. The PETHEMA group. Program for Study and Therapeutics of malignant hemopathies. Spanish Association of Hematology and Hemotherapy].
López-Guillermo A; García-Conde J; Alvarez-Carmona AM; León P; Maldonado J; Alcalá A; Zubizarreta A; Sancho-Tello R; Carbonell F; Contreras E; Besses C; Hernando A; Fontanillas M; Montserrat E
Med Clin (Barc); 1998 May; 110(16):601-4. PubMed ID: 9656196
[TBL] [Abstract][Full Text] [Related]
42. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
[TBL] [Abstract][Full Text] [Related]
43. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
44. Combination of cyclophosphamide, vincristine, and prednisone, followed by maintenance chemotherapy, with and without radiotherapy, in the management of patients with non-Hodgkin's lymphomas.
Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
Med Pediatr Oncol; 1977; 3(1):41-51. PubMed ID: 320448
[TBL] [Abstract][Full Text] [Related]
45. [Polychemotherapy in non-hodgkin lymphoma with a modified MOPP scheme (author's transl)].
Tigges FJ; Schmülling RM; Hiller E; Waller HD; Wilms K
Dtsch Med Wochenschr; 1977 Oct; 102(43):1537-41. PubMed ID: 334504
[TBL] [Abstract][Full Text] [Related]
46. Non-Hodgkin's lymphoma: patterns of relapse from complete remission after combination chemotherapy.
Schein PS; Chabner BA; Canellos GP; Young RC; DeVita VT
Cancer; 1975 Feb; 35(2):354-7. PubMed ID: 1089470
[TBL] [Abstract][Full Text] [Related]
47. Trichlortriethylamine (TS-160 Spofa) in combination chemotherapy of malignant lymphomas.
Klener P; Donner L
Neoplasma; 1975; 22(1):55-62. PubMed ID: 1097949
[TBL] [Abstract][Full Text] [Related]
48. Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphoma.
Schein PS; Chabner BA; Canellos GP; Young RC; Berard C; DeVita VT
Blood; 1974 Feb; 43(2):181-9. PubMed ID: 4589318
[No Abstract] [Full Text] [Related]
49. [Preliminary observations on the results of treating malignant lymphoma with Lycurim].
Polubiec A; Kolakowska-Polubiec K; Mariańska B; Perzanowska I
Acta Haematol Pol; 1977; 8(3):213-9. PubMed ID: 200051
[TBL] [Abstract][Full Text] [Related]
50. Non-Hodgkin's lymphomata: clinical features in relation to histology.
Van Unnik JA; Breur K; Burgers JM; Cleton F; Hart AA; Kroese WF; Somers R; Van Turnhout JM
Br J Cancer Suppl; 1975 Mar; 2():201-7. PubMed ID: 1101918
[TBL] [Abstract][Full Text] [Related]
51. Combination chemotherapy of lymphomas other than Hodgkin's disease.
Stein RS; Moran EM; Desser RK; Miller JB; Golomb HM; Ultmann JE
Ann Intern Med; 1974 Nov; 81(5):601-8. PubMed ID: 4608355
[No Abstract] [Full Text] [Related]
52. Prognostic significance of primary site after radiotherapy in non-Hodgkin's lymphomata.
Musshoff K; Schmidt-Vollmer H
Br J Cancer Suppl; 1975 Mar; 2():425-34. PubMed ID: 1101929
[TBL] [Abstract][Full Text] [Related]
53. The place of radiotherapy in the control of non-Hodgkin's lymphomata.
Peters MV; Bush RS; Brown TC; Reid J
Br J Cancer Suppl; 1975 Mar; 2():386-401. PubMed ID: 1101927
[No Abstract] [Full Text] [Related]
54. [Value of radiotherapy in disseminated highly malignant non-Hodgkin's lymphoma. Comment on the article by U. Kaiser, R. Pfab, K. Havemann, Strahlenther Onkol 1997, 173, 136-40 (No. 3)].
Stuschke M; Nowrousian MR
Strahlenther Onkol; 1998 Apr; 174(4):220. PubMed ID: 9581184
[No Abstract] [Full Text] [Related]
55. Management of generalized malignant lymphomata with "systemic" radiotherapy.
Johnson RE
Br J Cancer Suppl; 1975 Mar; 2():450-5. PubMed ID: 1242362
[TBL] [Abstract][Full Text] [Related]
56. Non-Hodgkin's lymphoma in Manitoba, 1968-77: the impact of chemotherapy.
Deonarine L; Weinerman BH; MacDougall BK; Kemel S
Can Med Assoc J; 1982 Apr; 126(7):807-11. PubMed ID: 7042060
[TBL] [Abstract][Full Text] [Related]
57. [Results of treatment of non-Hodgkin's lymphoma with telecobalt-60].
Wojcieszek Z; Majewski S
Pol Tyg Lek; 1979 Aug; 34(35):1375-7. PubMed ID: 388377
[No Abstract] [Full Text] [Related]
58. Non-Hodgkin's lymphoma: recent observations on natural history and intensive treatment.
Carbone PP
Cancer; 1972 Dec; 30(6):1511-6. PubMed ID: 4565816
[No Abstract] [Full Text] [Related]
59. [4-year-observation of results of VM 26 treatment of pathologic syndromes from the lymphoma malignum group].
Lawkowicz W; Polubiec A; Domańska B
Acta Haematol Pol; 1975; 6(2):143-7. PubMed ID: 1098351
[TBL] [Abstract][Full Text] [Related]
60. Reversal of red cell aplasia and marrow fibrosis in non-Hodgkin's lymphoma.
Kueh YK; Tan YO; Sng I; Rauff A
Ann Acad Med Singap; 1983 Jul; 12(3):472-3. PubMed ID: 6689579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
